Recent experimental studies have demonstrated that SIRT1 activity provides protection against atherosclerosis in ApoE−/− mice, either by modulating macrophage M1 polarization [45] or by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression [46]. The gene discussed is PCSK9; the disease is atherosclerosis.